Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real-world conditions-Multicenter analysis
| Image |  |
|---|---|
| Description | scientific article published on 24 May 2019 |
| Author/s |
author: Kojiro Michitaka Norio Itokawa Noritomo Shimada Korenobu Hayama Akemi Tsutsui Yohei Koizumi Real-life Practice Experts for HCC (RELPEC) Study Group, HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) Hidenori Toyoda Yoichi Hiasa Hironori Ochi Atsushi Hiraoka Kouji Joko Kazuto Tajiri Koichi Takaguchi Michitaka Imai Toru Ishikawa Masanori Atsukawa Masashi Hirooka Takuya Nagano Toshifumi Tada Kazuhiro Nouso Takashi Kumada Masatoshi Kudo Kazuya Kariyama |
| Publication date | May 24, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |